| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director | President &CEO
2 companies
Palasis Maria is a President &CEO at LYRA, with reported holdings spanning 2 companies. Recent filings cover 0 purchases and 6 sales. Those positions are worth an estimated $3.7M at current prices.
Our model assigns Palasis Maria a strong insider score of 85/100, based on 4 past trades. Over a 12-month horizon, 100.0% of those trades were profitable, with an average 12-month return of +94.0%.
Palasis Maria's largest disclosed position is in LYRA as President &CEO, worth about $3.7M. The recent filings there lean toward selling, a net 3,267 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jan 6, 2026 | LYRA Lyra Therapeutics, Inc. | President &CEO | Sell | 1,702 | $3.36 | $5,725.53 | -0.2% | -85.4% | - | |
| Dec 1, 2025 | BBNX Beta Bionics, Inc. | Director | Sell | 1,406 | $29.55 | $41,552.17 | -14.3% | -57.6% | - | |
| Oct 31, 2025 | BBNX Beta Bionics, Inc. | Director | Sell | 1,406 | $26.91 | $37,833.85 | -12.5% | -45.7% | - | |
| Jul 10, 2025 | LYRA Lyra Therapeutics, Inc. | President &CEO | Sell | 1,565 | $8.91 | $13,944.15 | -0.1% | -14.8% | -94.0% |